$MYO 3 SEC Filings

Filed On	Filing
13 Oct 2026	Form 3: McClure Mary-Katherine Hale, Chief Commericial Officer No securities owned
18 May 2026	Form 3: Manko Joseph M. Jr., Director Holds 2,108,578 shares of MYO
16 Apr 2026	Form 3: Febbo William J, Director No securities owned
28 Mar 2024	Form 3: Getz Heather C, Director No securities owned
24 Feb 2023	Form 3: Jacobovitz Yitzchak, Director
21 Jun 2021	Form 3: Morris Milton Mayo, Director Holds 0 shares of Common Stock
25 Mar 2021	Form 3: Kovelman Harry, Chief Medical Officer Holds 18,263 shares of Common Stock
20 Feb 2019	Form 3: Henry David A, Chief Financial Officer No securities owned
11 Jul 2018	Form 3: Mitchell Micah, Chief Commercial Officer No securities owned
13 Sep 2017	Form 3: Conneighton Cliff, Chief Marketing Officer Holds 10,188 shares of Common Stock
30 Aug 2017	Form 3: Green Brandon M, Chief Medical Officer
20 Jun 2017	Form 3: Mgc Venture Partners 2013, L.p., 10% owner Holds 678,105 shares of Common Stock
12 Jun 2017	Form 3: Sanghi Steve, Director
12 Jun 2017	Form 3: Naft Jonathan, VICE PRESIDENT, GM Holds 48,102 shares of COMMON STOCK
12 Jun 2017	Form 3: Mendelsohn Davie, VP, SALES & CLINICAL SERVICES Holds 17,705 shares of Common Stock
12 Jun 2017	Form 3: Knapp Amy K., Director
12 Jun 2017	Form 3: Kirk Thomas F, Director Holds 5,312 shares of COMMON STOCK
12 Jun 2017	Form 3: Gudonis Paul R, Director Holds 271,328 shares of COMMON STOCK
12 Jun 2017	Form 3: Goldwasser Ralph A, CHIEF FINANCIAL OFFICER Holds 9,538 shares of COMMON STOCK
12 Jun 2017	Form 3: Crowley Thomas Aloysius Jr., Director

Comments